Retrospective Analysis of Bevacizumab in Combination with Fotemustine in Chinese Patients with Recurrent Glioblastoma Multiforme

The aim of this study was to assess the activity and safety of bevacizumab (BEV) and fotemustine (FTM) for the treatment of recurrent glioblastoma multiforme (GBM) patients and explore the potential prognostic parameters on survival. This study retrospectively analyzed all patients with GBM who were...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biomed Res Int
Glavni autori: Liu, Zhiguang, Zhang, Guanqun, Zhu, Liang, Wang, Jiangbo, Liu, Dongbo, Lian, Lifei, Liu, Jianlin, Lai, Tianbao, Zhuang, Xiaorong
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348597/
https://ncbi.nlm.nih.gov/pubmed/25789324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/723612
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items